
Sign up to save your podcasts
Or
Resources for the Community:
___________________________________________________________________
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Ro GLP-1 Insurance Checker
https://ro.co/weight-loss/glp1-insurance-checker/
Ro GLP-1 Supply and Shortage Tracker
https://ro.co/weight-loss/supply-tracker/
Learn more about Obesity
https://www.obesityaction.org/
______________________________________________________________________
Today's episode is dedicated to addressing a controversial topic - compound pharmacies and GLP-1 medications. The lack of availability and affordability of medications like Ozempic, Wegovy, and Mounjaro has become a growing concern. In light of this, The Plus SideZ has invited specialists to educate the community on compounding pharmacies. There is not enough information available on this topic, and our community is in dire need of guidance. Join us as we speak with Dr. Daniel Rosen, Dr. Myra Ahmad, and Dr. Adam Ripley to explore the ins and outs of GLP-1 compounding pharmacies.
Our doctors have provided answers to some common questions regarding compound GLP-1 medications. They have addressed concerns about the safety of these medications and whether compound pharmacies are regulated. They have also explained that not all compound pharmacies are created equal and have highlighted some red flags that patients should look out for. Additionally, our doctors have addressed concerns about where compound pharmacies are sourcing drugs like Semaglutide or Tirzepatide, especially since retail brand manufacturers like Eli Lilly and Novo Nordisk have stated that they are not providing these medications to them.
Bios of our doctor guests
Dr. Daniel Rosen
https://www.weightzen.com/dr-daniel-j-rosen/
Daniel J. Rosen, MD – Dr. Rosen is a NYC bariatric surgeon. He specializes in the Lap-Band, Gastric Sleeve, Gastric Bypass, the Orbera Weight Loss Balloon, and Duodena
Send us Fan Mail!
Diabetes dialogues podcastListen on: Apple Podcasts Spotify
Support the show
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
4.5
175175 ratings
Resources for the Community:
___________________________________________________________________
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Ro GLP-1 Insurance Checker
https://ro.co/weight-loss/glp1-insurance-checker/
Ro GLP-1 Supply and Shortage Tracker
https://ro.co/weight-loss/supply-tracker/
Learn more about Obesity
https://www.obesityaction.org/
______________________________________________________________________
Today's episode is dedicated to addressing a controversial topic - compound pharmacies and GLP-1 medications. The lack of availability and affordability of medications like Ozempic, Wegovy, and Mounjaro has become a growing concern. In light of this, The Plus SideZ has invited specialists to educate the community on compounding pharmacies. There is not enough information available on this topic, and our community is in dire need of guidance. Join us as we speak with Dr. Daniel Rosen, Dr. Myra Ahmad, and Dr. Adam Ripley to explore the ins and outs of GLP-1 compounding pharmacies.
Our doctors have provided answers to some common questions regarding compound GLP-1 medications. They have addressed concerns about the safety of these medications and whether compound pharmacies are regulated. They have also explained that not all compound pharmacies are created equal and have highlighted some red flags that patients should look out for. Additionally, our doctors have addressed concerns about where compound pharmacies are sourcing drugs like Semaglutide or Tirzepatide, especially since retail brand manufacturers like Eli Lilly and Novo Nordisk have stated that they are not providing these medications to them.
Bios of our doctor guests
Dr. Daniel Rosen
https://www.weightzen.com/dr-daniel-j-rosen/
Daniel J. Rosen, MD – Dr. Rosen is a NYC bariatric surgeon. He specializes in the Lap-Band, Gastric Sleeve, Gastric Bypass, the Orbera Weight Loss Balloon, and Duodena
Send us Fan Mail!
Diabetes dialogues podcastListen on: Apple Podcasts Spotify
Support the show
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
2,105 Listeners
334 Listeners
46 Listeners
69 Listeners
280 Listeners
1,649 Listeners
36 Listeners
370 Listeners
76 Listeners
60 Listeners
203 Listeners
22 Listeners
104 Listeners
239 Listeners
65 Listeners